DDX41 and acute myeloid leukemia: First identified in 2015 as predisposing mutations for myeloid neoplasms by a study of an index family with a strong history of MDS/AML, a significant proportion of hereditary myeloid neoplasms were associated with the DDX41 mutations by affecting RNA biology and innate immunity [34].